FL118 for Treating Patients With Advanced Pancreatic Ductal Adenocarcinoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Clinical Trials Related to Metastatic Pancreatic Ductal Adenocarcinoma
Related studies linked through entity extraction aliases.
A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9
- Status
- WITHDRAWN
- Phase
- PHASE1
CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer
- Status
- SUSPENDED
- Phase
- PHASE1
Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Botensilimab in Participants With Metastatic Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
BXCL701 and Pembrolizumab in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC (NALPAC)
- Status
- RECRUITING
- Phase
- PHASE2
Retrospective Study on the Efficacy and Tolerability of Liposomal Irinotecan
- Status
- UNKNOWN
- Phase
- N/A
A Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of the Safety and Tolerance of CAN04 in Combination With FOLFIRINOX in Subjects With Metastatic Pancreatic Ductal Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Study of Efficacy and Safety of NIS793 in Combination With Standard of Care (SOC) Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) - daNIS-2
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of Mitazalimab in Combination With Chemotherapy in Pancreatic Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Mesothelin-Specific T-Cells (FH-TCR-Tᴍsʟɴ) for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Pembrolizumab and Olaparib for People With Metastatic Pancreatic Ductal Adenocarcinoma and Homologous Recombination Deficiency or Exceptional Treatment Response to Platinum-Based Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study Evaluating the Ketogenic Diet in Patients With Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- NA
A Phase 1B Study of Canakinumab, Spartalizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer (PC) Patients
- Status
- COMPLETED
- Phase
- PHASE1
A Pilot Study of Ciprofloxacin Plus Gemcitabine and Nab-Paclitaxel Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Niraparib and Dostarlimab for the Treatment of Germline or Somatic BRCA1/2 and PALB2 Mutated Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2